Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3686554018 | Product containing hydroflumethiazide and spironolactone in oral dosage form (medicinal product form) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3686555017 | Hydroflumethiazide and spironolactone in oral dosage form | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3686556016 | Product containing hydroflumethiazide and spironolactone in oral dosage form | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3710333010 | Product containing hydroflumethiazide and spironolactone in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3710334016 | Hydroflumethiazide- and spironolactone-containing product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing hydroflumethiazide and spironolactone in oral dose form (medicinal product form) | Has active ingredient | Spironolactone (substance) | true | Inferred relationship | Some | 1 | |
| Product containing hydroflumethiazide and spironolactone in oral dose form (medicinal product form) | Is a | Product containing hydroflumethiazide and spironolactone (medicinal product) | true | Inferred relationship | Some | ||
| Product containing hydroflumethiazide and spironolactone in oral dose form (medicinal product form) | Is a | Product containing hydroflumethiazide in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing hydroflumethiazide and spironolactone in oral dose form (medicinal product form) | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
| Product containing hydroflumethiazide and spironolactone in oral dose form (medicinal product form) | Is a | Product containing spironolactone in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing hydroflumethiazide and spironolactone in oral dose form (medicinal product form) | Has active ingredient | Hydroflumethiazide (substance) | true | Inferred relationship | Some | 2 | |
| Product containing hydroflumethiazide and spironolactone in oral dose form (medicinal product form) | Plays role | Potassium-sparing diuretic therapeutic role (role) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Hydroflumethiazide 25 mg and spironolactone 25 mg oral tablet | Is a | False | Product containing hydroflumethiazide and spironolactone in oral dose form (medicinal product form) | Inferred relationship | Some | |
| Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Is a | False | Product containing hydroflumethiazide and spironolactone in oral dose form (medicinal product form) | Inferred relationship | Some | |
| Product containing only hydroflumethiazide and spironolactone in oral dose form (medicinal product form) | Is a | True | Product containing hydroflumethiazide and spironolactone in oral dose form (medicinal product form) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR